Intracardiac echocardiographic imaging of the left ventricle from the right ventricle: quantitative experimental evaluation.

PURPOSE: Our purpose was to demonstrate that intracardiac ultrasound imaging from a transducer placed in the right ventricle can be used to quantitatively image the left ventricle in a swine model. BACKGROUND: The left ventricles and right ventricles of dogs and human beings have been studied with intracardiac echocardiography. Usually intracardiac echocardiography has been performed with the ultrasound catheter in the chamber being studied because of limited depth of field. Thus left ventricular imaging required that the ultrasound catheter be placed intra-arterially and manipulated into the left ventricle. The availability of lower frequency ultrasound catheters may allow left ventricular imaging from the right ventricle--a more clinically attractive approach. METHODS: In 10 closed chest swine, a 10F, 10-MHz ultrasound catheter was placed into the right ventricle through an introducer sheath placed in the right internal jugular vein. Two-dimensional transthoracic echo images were obtained for comparison. Two protocols were used to image global left ventricular function and regional wall motion during pharmacologic challenge. In protocol 1 (n = 4) we evaluated global left ventricular performance in response to interventions: dobutamine, halothane (a myocardial depressant), nitroprusside, and volume loading. In protocol 2 (n = 6) we evaluated regional contraction abnormalities induced by coronary arterial balloon inflation and deflation (reperfusion) and dobutamine. At baseline and after each intervention, global function of the right ventricle and left ventricle was measured as cross-sectional end-diastolic area and end-systolic area, and regional contraction was evaluated as the percentage of left ventricular circumference with a wall motion abnormality. Intracardiac pressures and cardiac output were also measured for comparison. Left ventricular cross-sectional area ejection fractions (area EF) were calculated for both intracardiac and transthoracic echo images as (end-diastolic cross-sectional area - end-systolic cross-sectional area)/end-diastolic cross-sectional area. RESULTS: The 10F, 10-MHz intracardiac ultrasound catheter successfully imaged the left ventricle from the right ventricle in all 10 swine. In protocol 1, dobutamine increased area EF from a baseline of 0.60 +/- 0.03 to 0.87 +/- 0.04 (P < .05). When dobutamine was added to the myocardial depressant halothane, left ventricular area EF increased from a baseline of 0.55 +/- 0.03 to 0.68 +/- 0.04. In protocol 2, coronary occlusion resulted in a detectable regional wall motion abnormality (circumferential percentage) of 23% +/- 3%. After reperfusion and during dobutamine stimulation, the wall abnormality decreased to 12% +/- 4%. Transthoracic echocardiography correlated well with these intracardiac findings. CONCLUSIONS: The left ventricle can be quantitatively imaged from the right ventricle with the use of a 10F, 10-MHz intracardiac catheter in swine. This system can detect changes in global and regional left ventricular systolic function. This technique warrants evaluation in clinical applications.

Tissue characterization in intravascular ultrasound images.

Intravascular ultrasound (IVUS) imaging permits direct visualization of vascular pathology. It has been used to evaluate lumen and plaque in coronary arteries and its clinical significance for guidance of coronary interventions is increasingly recognized. Conventional manual evaluation is tedious and time-consuming. This paper describes a highly automated approach to segmentation of coronary wall and plaque, and determination of plaque composition in individual IVUS images and pullback image sequences. The determined regions of plaque were classified in one of three classes: soft plaque, hard plaque, or hard plaque shadow. The method's performance was assessed in vitro and in vivo in comparison with observer-defined independent standards. In the analyzed images and image sequences, the mean border positioning error of the wall and plaque borders ranged from 0.13-0.17 mm. Plaque classification correctness was 90%.

Intracardiac versus transthoracic echocardiographic imaging of translation and rotation of left ventricular center of cavity area in dogs.

Motion of the left ventricular cavity center during the cardiac cycle was compared using transthoracic and intracardiac echocardiography. Rotation was comparable for the 2 methods, however, translation of the left ventricular cavity area center was greater with intracardiac echocardiography.

Intracardiac ultrasound detection of right ventricular infarction in a canine model.

Our objective was to demonstrate that right ventricular (RV) infarction could be demonstrated by intracardiac ultrasonography in a canine model. RV infarction is a common and important clinical condition in patients with myocardial infarction. Traditional methods for diagnosing RV infarction have limitations. Intracardiac echocardiography, in which an ultrasonic transducer on the tip of a catheter is placed intravenously into the RV chamber, should allow detection of RV infarction. Nine closed-chest dogs were studied. The animals were instrumented with a 10 MHz ultrasound catheter placed into the right ventricle. The right coronary artery was occluded with a balloon angioplasty catheter for 20 minutes and subsequently embolized with elemental mercury. Intracardiac ultrasound images were obtained at baseline, during balloon occlusion, and during embolization. RV cross-sectional end-diastolic and end-systolic areas were calculated and fractional area changes were calculated; RV wall motion abnormalities were also evaluated. The interventricular septal thickening was also calculated. The 10 MHz intracardiac ultrasound catheter allowed visualization of much of the RV chamber and interventricular septum. The RV cross-sectional area increased with mercury embolization, which was also associated with regional wall motion abnormalities. RV end-systolic area was 1.6 cm2 and end-diastolic area 3.9 cm2 at baseline; these increased to 4.8 cm2 and 6.5 cm2 after embolization (p < 0.05). Interventricular septal thickening remained unchanged. The echocardiographic features of RV infarction, which include RV dilation and RV regional wall motion abnormalities, could be demonstrated in a canine infarct model with a 10 MHz intracardiac ultrasound catheter.

Towards a geometrically correct 3-D reconstruction of tortuous coronary arteries based on biplane angiography and intravascular ultrasound.

At present, 3-D reconstructions of coronary vessels are generated from intravascular ultrasound (IVUS) by stacking up ECG-gated segmented IVUS frames of a pullback sequence. This simplified approach always results in straight vessel reconstructions and, therefore, gives an incorrect representation of tortuous coronary arteries. A more realistic reconstruction of tortuous vessels may be obtained by data fusion with biplane angiography. The 3-D course of the vessel is first derived from the angiograms and then combined with the segmented IVUS images. In this paper, we focus on two problems associated with the data fusion method: The definition of the pullback path and the estimation of the IVUS catheter twist during pullback. A robust algorithm for calculation of tortuosity-induced catheter twist is reported that is based on sequential triangulation of the 3-D pullback path. The method is analyzed with computer simulations and validated in helical vessel phantoms. A largely automated data fusion approach is proposed and applied to tortuous coronary arteries in cadaveric pig hearts.

Electron beam computed tomography: use in pulmonary embolectomy.

Proximal chronic pulmonary emboli with severe pulmonary hypertension were diagnosed by electron-beam computed tomography and Doppler echocardiography. After successful embolectomy, repeat examinations showed normal pulmonary artery pressures and patency. Electron beam computed tomography can noninvasively identify surgically treatable pulmonary emboli.

Segmentation of intravascular ultrasound images: a knowledge-based approach.

Intravascular ultrasound imaging of coronary arteries provides important information about coronary lumen, wall, and plaque characteristics. Quantitative studies of coronary atherosclerosis using intravascular ultrasound and manual identification of wall and plaque borders are limited by the need for observers with substantial experience and the tedious nature of manual border detection. We have developed a method for segmentation of intravascular ultrasound images that identifies the internal and external elastic laminae and the plaque-lumen interface. The border detection algorithm was evaluated in a set of 38 intravascular ultrasound images acquired from fresh cadaveric hearts using a 30 MHz imaging catheter. To assess the performance of our border detection method we compared five quantitative measures of arterial anatomy derived from computer-detected borders with measures derived from borders manually defined by expert observers. Computer-detected and observer-defined lumen areas correlated very well (r=0.96, y=1.02x+0.52), as did plaque areas (r=0.95, y=1.07x-0.48), and percent area stenosis (r=0.93, y=0.99x-1.34.) Computer-derived segmental plaque thickness measurements were highly accurate. Our knowledge-based intravascular ultrasound segmentation method shows substantial promise for the quantitative analysis of in vivo intravascular ultrasound image data.

Prediction of change in mitral valve area after mitral balloon commissurotomy using cine computed tomography.

RATIONALE AND OBJECTIVES: Mitral balloon commissurotomy (MBC) can successfully increase the mitral valve area (MVA) in mitral stenosis, but the outcome is variable. In multicenter studies, qualitative echocardiographic scores obtained before MBC are only weakly predictive of the increase in MVA after MBC. METHODS: To evaluate whether the change in MVA after MBC can be predicted by evaluating mitral valve morphology using cine computed tomography (CT), we studied 12 women with mitral stenosis and 11 female control subjects. RESULTS: In the patients with mitral stenosis, MVA increased from 1.13 +/- 0.24 to 1.93 +/- 0.56 cm2 (P < .0001) after MBC. A standard echocardiographic score assessment of mitral valve morphology before MBC was not associated with the change in MVA after MBC in these patients (P > .20). However, the total mitral valve morphology score evaluated by cine computed tomography was strongly associated with the change in MVA after MBC (r = -.87; P < .0005). In addition, the individual morphologic characteristics of mitral valve mobility (P < .0025), leaflet thickness (P < .05), and subvalvular disease (P < .05) were significant predictors of the change in MVA after MBC. CONCLUSION: Cine computed tomography may be useful for predicting immediate increases in MVA in patients after MBC and may be helpful for preoperative assessment of these patients.

Assessment of cardiac volumes and left ventricular mass by cine computed tomography before and after mitral balloon commissurotomy.

We used cine computed tomography (CT) to determine whether decreased mitral valve gradients and pulmonary artery pressures resulted in decreased right ventricular and atrial volumes after percutaneous mitral balloon commissurotomy (MBC). In patients treated for severe mitral stenosis, previous studies have shown that after the mitral valve gradient decreases, the left atrial volume is reduced and left ventricular stroke volume is increased. The effects of commissurotomy on right heart chamber sizes have been difficult to assess with angiography and echocardiography. Moreover, in follow-up studies performed after surgery, changes in cardiac chamber volumes occurring after the mitral valve gradient and pulmonary pressure are reduced are confounded by the effects of thoracotomy. Our group has previously demonstrated that cine CT can accurately measure both left and right cardiac chamber volumes. We studied 11 female patients before, immediately after, and at 1 year after MBC, and 9 female control subjects of comparable age. To assess cardiac chamber volumes, we used cine CT. To assess the effects of MBC, we used cardiac catheterization and Doppler echocardiography.(ABSTRACT TRUNCATED AT 250 WORDS)

Histological and angiographic effects of a pulsed holmium:YAG laser in normal and atherosclerotic human coronary arteries and aorta.

OBJECTIVE: The aims were (1) To determine the histological and angiographic effects of holmium:YAG laser energy delivered through clinical multifibre laser catheters on fresh cadaveric coronary arteries; and (2) to relate the placement of optical fibres in the catheter to patterns of tissue ablation in cadaveric aorta. METHODS: Eight fresh cadaveric hearts and segments of aorta were used. Hearts were mounted on a new pressure perfusion device. The laser catheter was delivered over a guidewire in the lumen until it met an area of resistance. The coronary artery lumen was perfused at approximately 100 mm Hg mean pressure. These arterial areas were identified on angiography, marked, and then exposed to laser energy in the range 600-3000 mJ.mm-2. Normal and atherosclerotic areas of fresh cadaveric aortic strips were exposed to increasing laser energies using either constant or increasing fluence. Coronary arteries were pressure perfused with formalin for 18-24 h at 100 mm Hg mean pressure, and aortic strips were immersed in 5% formalin. Light and scanning electron microscopy studies were carried out. RESULTS: There were no perforations or dissections by angiography in the fresh coronary arteries. One of 15 normal coronary artery segments and 10 of 16 of the pressure perfused, fixed, atherosclerotic coronary artery segments showed thermal changes associated with atherosclerotic plaque ablation. In aortic tissue, thermal effects extended 0 to 0.6 mm lateral to the ablated crater. Acoustic effects were seen only in the aortic strips after ablation at fluences > 1000 mJ.mm-2. The "dead spaces" around the optical fibres in the catheter resulted in significant amounts of coagulated tissue fragments remaining in the crater. CONCLUSIONS: Holmium:YAG laser energy delivered through multifibre catheters ablated atherosclerotic tissue in coronary arteries with minimal damage to the normal walls. The cadaveric coronary artery perfusion apparatus is useful for assessing catheter delivery and mobility and the effects of laser energy on the coaxially orientated normal and atherosclerotic coronary arterial wall.

Influence of mitral valve morphology on mitral balloon commissurotomy: immediate and six-month results from the NHLBI Balloon Valvuloplasty Registry.

Echocardiographic data were analyzed in 555 patients undergoing mitral balloon commissurotomy (MBC). Patients were enrolled in the National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry from 24 centers. There were 456 women and 99 men with a mean age of 54 years. Before MBC the two-dimensional echocardiographic variables of mitral valve thickness, mobility, calcification, and subvalvular disease were evaluated and assigned scores of 1 to 4. The mitral valve morphology score was related to mitral valve area (MVA) measured after MBC by cardiac catheterization. The leaflet mobility score was related to the immediate post-MBC MVA: 2.2 +/- 0.8 cm2 for grade 1, 1.9 +/- 0.7 cm2 for grade 2, 1.7 +/- 0.7 cm2 for grade 3, and 1.9 +/- 0.9 cm2 for grade 4 (p less than 0.001). Results of the MVA after MBC showed a similar relationship for each echocardiographic variable. The total morphology score (sum of the four variables) showed a weak relationship to MVA immediately after MBC (r = 0.24), which was persistent at 6 months after MBC (r = -0.25). Multiple regression analysis showed that the MVA after MBC is predicted by pre-MBC MVA (p less than 0.001), left atrial size (p = 0.01), balloon diameter (p = 0.02), cardiac output (p = 0.004), and leaflet mobility (p = 0.01). The R2 of the model was 0.31 (p less than 0.001). Total morphology score, leaflet thickness, calcification, and subvalvular disease were not important univariate or multivariate predictors of the results of MBC.(ABSTRACT TRUNCATED AT 250 WORDS)

Double-blind comparison of the clinical, hemodynamic, and electrocardiographic effects of sodium meglumine ioxaglate or iohexol during diagnostic cardiac catheterization.

The clinical effects and the maximal hemodynamic and electrocardiographic effects of two low-osmolality radiographic contrast media (ioxaglate and iohexol) were directly compared during diagnostic cardiac catheterization in a double-blind, randomized study in 80 patients. Because small changes were expected after injection of both of these agents, sensitive ECG and intracardiac-pressure-monitoring methods were used, and maximal changes, as well as mean changes in variables, were analyzed. Symptoms were absent, mild, or moderate in 67-77% of patients after left ventriculography and in 97-100% of patients after coronary arteriography. After left ventriculography, maximum and minimum left ventricular systolic pressure and end-diastolic pressure, the first derivative of left ventricular pressure (dp/dt), heart rate, were significantly altered over the two-minute observation period but were not different from the preinjection values at two minutes after both agents. Small but significant increases in mean aortic pressure, cardiac output, and pulmonary arterial wedge pressures were seen at two minutes after both agents.

Coronary artery disease and cardiac events with asymptomatic and symptomatic cerebrovascular disease.

BACKGROUND AND PURPOSE: The purpose of this study was to evaluate the prevalence of coronary artery disease and coronary events during follow-up in patients with asymptomatic carotid stenosis, transient ischemic attacks, or small strokes. METHODS: We prospectively studied 60 consecutive patients with thallium-201 scintigraphy followed by coronary arteriography according to an established protocol. RESULTS: The 201Tl testing was abnormal in seven of 15 patients (47%) with asymptomatic carotid stenosis and in 19 of 44 patients (43%) with transient ischemic attacks or small strokes (p greater than 0.05). In 33 patients with no history of coronary artery disease, 11 (33%) had reversible 201Tl defects. In 26 patients with a history of coronary artery disease, 15 (58%) had reversible and/or fixed defects (p = 0.054 compared with patients with no history). A history of peripheral vascular disease was the only risk factor significantly associated with an abnormal 201Tl test (p = 0.032). Coronary artery stenosis of greater than 50% was identified in one or more vessels in 14 of 15 patients undergoing coronary arteriography. Over a mean follow-up period of 311 days, four patients (7%) developed new onset of angina. There were four coronary events among 14 patients (29%) with both a reversible area on the 201Tl and abnormal coronary arteriography. In comparison, there were only four coronary events among 46 patients (9%) without reversible defects on the 201Tl studies (p = 0.055). CONCLUSIONS: Our study demonstrates that one third of patients with no history of coronary artery disease had an abnormal 201Tl test and that nearly one half of patients with either symptomatic or asymptomatic cerebrovascular disease had abnormal 201Tl tests. Patients with a reversible 201Tl defect and significant stenosis by coronary arteriography were at higher risk for subsequent cardiac events. These findings demonstrate the utility of screening patients with asymptomatic and symptomatic cerebrovascular disease for cardiac disease.

Should patients with mitral stenosis who are acceptable surgical commissurotomy candidates now have balloon valvuloplasty treatment?

This review of the surgical and valvuloplasty literature demonstrates that mitral valve morphology rather than the type of intervention determines the therapeutic results after surgical commissurotomy or balloon valvuloplasty treatment of mitral stenosis. The mechanism of dilatation and hemodynamic results of transventricular mitral commissurotomy and of mitral balloon valvuloplasty are similar. Both techniques should be considered palliative. Because the balloon catheter technique can achieve hemodynamic results similar to surgery and may delay the trauma and expense of surgery, it can be offered to patients as a primary treatment for relief of symptomatic mitral stenosis.

Early treatment with intravenous metoprolol for suspected acute myocardial infarction: a phase IV United States trial. Phase IV Metoprolol in Myocardial Infarction Study Group.

Recent randomized clinical trials have shown that total mortality and cardiovascular mortality are reduced by the early intravenous administration of beta-blockers to patients suspected of suffering from acute myocardial infarction. These trials were conducted on patients meeting strict entry criteria. In order to assess this therapy when applied to a broader range of myocardial infarction patients, we performed a Phase IV study of metoprolol in acute myocardial infarction. The study was designed to test whether early (less than 8 hours from onset of chest pain) intervention by practicing physicians with open label intravenous metoprolol for cases of suspected acute myocardial infarction achieved mortality results similar to those obtained in large randomized clinical trials. We studied 3824 patients treated by 741 physicians representing a broad spectrum of clinical practice in the United States. Seventy-two percent of the patients entered into the study had confirmed myocardial infarction (39% anterior, 39% inferior, 22% other locations) and 85% of all individuals treated tolerated the full intravenous dose of 15 mg of metoprolol. The 15 day total mortality and cardiovascular mortality rates were 4.9% and 4.5%; 90 day mortality rates were 6.9 and 5.9%. Patients with anterior infarctions had a significantly greater cumulative mortality rate than patients with other types of infarctions. Marked bradycardia (heart rate less than 45 beats per minute) in the first 8 hours post treatment occurred in 4.7% cases and hypotension (systolic blood pressure less than 90 mm Hg) occurred in 9.8% of cases. When compared with the results of the Göteborg and MIAMI trials of metoprolol, it appears that there is no appreciable increase in mortality or morbidity when metoprolol is used in the community practice of acute coronary care.